QUMAS Expert to Moderate Panel Discussion on Time-to-Market Strategies at Prestigious BIOCOM Breakfast Series (Market Wire via Yahoo! Finance)
QUMAS, the leading developer of enterprise governance, risk and compliance solutions, announced today Warren Perry, compliance advisor, at QUMAS, will moderate the June 14th BIOCOM breakfast at the La Jolla Marriott, in La Jolla, California, at 7:00 a.m.

Cervical cancer vaccine gets FDA backing but high cost may deter sponsors (EARTHtimes.org)
NEW YORK: The Food and Drug Administration yesterday awarded license to the world's first vaccine for cervical cancer. The vaccine named Gardasil was tested over 21,000 women around the world over the last six months. Although hailed as breakthrough, the vaccine has raised questions about who will bear the cost of dispensing the vaccine.

Investigational Treatment Ruboxistaurin Demonstrated Promise in Reducing the Occurrence of Vision Loss Caused By (RedNova)
WASHINGTON, D.C., June 11 /PRNewswire-FirstCal